The Cooper Companies, Inc. (COO)
The Cooper Companies (COO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for The Cooper Companies (COO) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The Cooper Companies (COO) Q4 Earnings and Revenues Surpass Estimates
The Cooper Companies (COO) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.04 per share a year ago.
Cooper Companies to Post Q4 Earnings: What's in Store for the Stock?
COO is set to post Q4 earnings as MyDAY momentum offsets Clariti and APAC softness, with revenues and earnings expected to rise.
Curious about The Cooper Companies (COO) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Evaluate the expected performance of The Cooper Companies (COO) for the quarter ended October 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy?
The Cooper Companies (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Cooper Companies: Defensive Gem With Insider Buying And Building Momentum
Cooper Companies may strongly outperform the S&P 500 going forward, especially in a recessionary environment, rebounding from 2025's sell-off. COO trades at decade-low enterprise valuations, with renewed insider buying, positive trading momentum, and a history of resilience during economic downturns. The company leads the global contact lens market, maintains a solid balance sheet, and just expanded its share repurchase program by $1 billion.
Reasons to Retain Cooper Companies Stock in Your Portfolio for Now
COO's premium lens strategy, MiSight myopia leadership, and fertility portfolio fuel long-term growth despite near-term headwinds.
Here's Why The Cooper Companies (COO) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
COO vs. MMSI: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either The Cooper Companies (COO) or Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?
How Much Upside is Left in The Cooper Companies (COO)? Wall Street Analysts Think 26.47%
The consensus price target hints at a 26.5% upside potential for The Cooper Companies (COO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand
COO's Q3 results may top estimates, powered by strong demand for MyDay lenses, Biofinity gains and surgical product resilience despite fertility softness.
The Cooper Companies (COO) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Besides Wall Street's top-and-bottom-line estimates for The Cooper Companies (COO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2025.
